Clinical Trial Update: Study on Single and Multiple Atomization Inhalation of HRS-9821 Suspension for Inhalation in Healthy Subjects and COPD Patients [Phase 1]

View source ↗

Summary

Phase 1 study evaluating single and multiple atomization inhalation of HRS-9821 suspension for inhalation in healthy subjects and COPD patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• HRS-9821

Snippet

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd | Conditions: Chronic Obstructive Pulmonary Disease | Phase 1 | Status: COMPLETED